Merge branch 'main' of https://github.com/UoA-eResearch/pharmac

OFI.csv

@@ -43,7 +43,6 @@ Denosumab,/apptracker/s/application-public/a102P000008pu0f,"Osteoporosis, contra
 Denosumab,/apptracker/s/application-public/a102P00000BIKVx,"Hypercalcemia in people with malignant bone disease and renal impairment, second line",
 Denosumab,/apptracker/s/application-public/a102P00000BKJ7c,"Osteoporosis, contraindicated to bisphosphonates",Musculoskeletal System
 Durvalumab,/apptracker/s/application-public/a102P00000Bajp3,"biliary tract cancer, Locally advanced or metastatic, in combination with chemotherapy",Oncology Agents and Immunosuppressants
-Empagliflozin,/apptracker/s/application-public/a102P00000BNybx,"Chronic heart failure, NYHA II-IV and LVEF ≤40%",Cardiovascular System
 Entrectinib,/apptracker/s/application-public/a102P00000ASxy1,"Non-small cell lung cancer (NSCLC) - adult patients with ROS1-positive, locally advanced or metastatic",Oncology Agents and Immunosuppressants
 Enzalutamide,/apptracker/s/application-public/a102P00000BKbSL,"Prostate cancer, metastatic, castration resistant, contraindicated to abiraterone",Oncology Agents and Immunosuppressants
 Eplerenone,/apptracker/s/application-public/a102P000008puD9,"Hypertension, treatment refractory, intolerant to spironolactone",Cardiovascular System